Skip to Content for 2007 Annual Report Menu for 2007 Annual Report About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

2007 Annual Report

Editorial Financials

Directors, Officers and Distinguished Contributors
Board of Directors Arthur D. Levinson, Ph.D.
Chairman and Chief Executive Officer,
Genentech

Herbert W. Boyer, Ph.D.
Co-founder of Genentech and Professor
Emeritus of Biochemistry and Biophysics,
University of California, San Francisco

William M. Burns
Chief Executive Officer of the Pharmaceuticals
Division and Member of the Corporate
Executive Committee, The Roche Group

Erich Hunziker, Ph.D.
Chief Financial Officer
and Deputy Head of the Corporate Executive
Committee, The Roche Group

  
   Jonathan K. C. Knowles, Ph.D.
Head of Global Research and Member of the
Corporate Executive Committee,
The Roche Group

Debra L. Reed
President and Chief Executive Officer,
San Diego Gas & Electric and Southern
California Gas Company

Charles A. Sanders, M.D.
Lead Director of Genentech and
former Chairman and Chief Executive
Officer, Glaxo, Inc.

Officers Arthur D. Levinson, Ph.D.*
Chairman and Chief Executive Officer

Susan D. Desmond-Hellmann, M.D., M.P.H.*
President, Product Development

Ian T. Clark*
Executive Vice President, Commercial

David A. Ebersman*
Executive Vice President and Chief
Financial Officer

Stephen G. Juelsgaard, D.V.M., J.D.*
Executive Vice President, Secretary and
Chief Compliance Officer

Richard H. Scheller, Ph.D.*
Executive Vice President, Research

Patrick Y. Yang, Ph.D.*
Executive Vice President, Product Operations

William N. Anderson
Senior Vice President, Sales and Marketing, Immunology

Hal Barron, M.D.
Senior Vice President, Development, and
Chief Medical Officer

Andrew C. Chan, M.D., Ph.D.
Senior Vice President, Immunology

Markus Gemuend
Senior Vice President, Biochemical Manufacturing

Sean A. Johnston, J.D., Ph.D.
Senior Vice President and General Counsel

Timothy L. Moore
Senior Vice President, Global Supply Chain
and Corporate Engineering

John Orwin
Senior Vice President, Sales and Marketing, BioOncology

David Schenkein, M.D.
Senior Vice President, Clinical Hematology/Oncology

Marc Tessier-Lavigne, Ph.D.
Senior Vice President, Research Drug Discovery

Robert Andreatta
Controller and Chief Accounting Officer

Vince Anicetti
Vice President, Biochemical Quality

Philippe Bishop, M.D.
Vice President, Clinical Development, Avastin

Glenn Brame Vice President, Global Supply Chain Quality

David F. Broad, Ph.D.
Vice President, Biochemical Manufacturing, Oceanside

Charles Calderaro III
Vice President and General Manager,
Vacaville Product Operations

Peter A. Carberry, M.D.
Vice President, Clinical Operations,
Development Planning and Performance Analysis

Scott Carmer
Vice President, Sales and Marketing, Rituxan Immunology

Christine Castro
Vice President, Corporate Relations

Jennifer E. Cook
Vice President, Product Portfolio Management

Frederic de Sauvage, Ph.D.
Vice President, Research, Molecular Biology

Vishva Dixit, M.D.
Vice President, Early Discovery Research

John Doyle
Vice President, Finance and Corporate Planning

Khurem Farooq
Vice President, Sales and Marketing, Xolair

Robert L. Garnick, Ph.D.
Vice President, Ophthalmic Device Development

Odette Go
Treasurer

Ashraf Hanna, M.D., Ph.D.
Vice President, Alliance Management,
Pipeline and Portfolio Planning

  

  Gary Harbour, Ph.D.
Vice President and General Manager,
Oceanside Product Operations

Roy C. Hardiman, J.D.
Vice President, Corporate Law, and
Assistant Secretary

Susan Hershenson, Ph.D.
Vice President, Pharmaceutical and Device Development

Kenneth J. Hillan, M.B., Ch.B.
Vice President, Clinical Immunology,
Tissue Growth and Repair

Chris Horan
Vice President, Planning, Distribution and Logistics

Anthony P. Hurley
Vice President, South San Francisco
Production

Leonard Kanavy
Vice President, Commercial Operations

Stephen Kelsey, M.D. Vice President, Clinical Hematology/Oncology

Sara Kenkare-Mitra, Ph.D.
Vice President, Development Sciences

Ann L. Lee, Ph.D.
Vice President, Process Research and Development

Kent E. Lieginger, Pharm.D.
Vice President, Managed Care and
Customer Operations

Thomas G. Lyon
Vice President, Business Services

Joseph S. McCracken, D.V.M.
Vice President, Business Development

Ira Mellman, Ph.D.
Vice President, Research, Oncology

James P. Miller
Vice President and General Manager,
Singapore Product Operations

Michael P. Miller
Vice President, Sales and Marketing,
HER Family¹

Walter K. Moore
Vice President, Government Affairs

Genesio Murano, Ph.D.
Vice President, Regulatory Policy and Strategy

Varun Nanda
Vice President, Sales and Marketing, Avastin

Philippa Norman
Vice President, Manufacturing Collaborations

Quinton C. Oswald
Vice President, Sales and Marketing,
Tissue Growth and Repair

Todd Pierce
Vice President, Corporate Information Technology

John R. Pinion
Vice President, Quality and Compliance

Jon Reed
Vice President, Corporate Engineering

Todd W. Rich, M.D.
Vice President, Development Regulatory,
Medical Information, Drug Safety and
Quality Assurance

Corsee D. Sanders, Ph.D.
Vice President, Design, Analysis,
Technology and Administration (DATA) for
Development Organization

Mary B. Sliwkowski, Ph.D.
Vice President, Regulatory Chemistry
Manufacturing and Controls and Information Systems

Denise Smith-Hams
Vice President, Human Resources

John Snisarenko
Vice President, Sales and Marketing, Lucentis

Michael D. Varney, Ph.D.
Vice President, Small Molecule Drug Discovery

John M. Whiting
Vice President, Finance, Treasury and Procurement
* Member of Executive Committee

Genentech Fellow Napoleone Ferrara, M.D.
Research

  
  

Senior Staff Scientist Avi J. Ashkenazi, Ph.D.
Research

  

  Gwendolyn Fyfe, M.D.
Development

Staff Scientists Thomas A. Bewley, Ph.D.
Process Development

Stuart Bunting, Ph.D.
Research

Frederic de Sauvage, Ph.D.
Research

Vishva Dixit, M.D.
Research

David Giltinan, Ph.D.
Development

Peter Jackson, Ph.D.
Research

  

  Paul Godowski, Ph.D.
Research

Paul Polakis, Ph.D.
Research

Steve Shire, Ph.D.
Process Development

Mark Sliwkowski, Ph.D.
Research

Hergen Spits, Ph.D.
Research

Richard Vandlen, Ph.D.
Research

Distinguished Engineers Chung Hsu, Ph.D., P.E.
Process Development

Brad Snedecor
Process Development

  

  Robert van Reis
Process Development

Bradley Wolk
Process Development

Distinguished Programmer Analyst Colin Watanabe
Corporate Information Technology

  

 

¹ The HER Family includes the oncology products Herceptin and Tarceva.